MXPA02012326A - Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso. - Google Patents
Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso.Info
- Publication number
- MXPA02012326A MXPA02012326A MXPA02012326A MXPA02012326A MXPA02012326A MX PA02012326 A MXPA02012326 A MX PA02012326A MX PA02012326 A MXPA02012326 A MX PA02012326A MX PA02012326 A MXPA02012326 A MX PA02012326A MX PA02012326 A MXPA02012326 A MX PA02012326A
- Authority
- MX
- Mexico
- Prior art keywords
- chemically
- compositions
- methods
- production
- modified peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Se divulgan composiciones y metodos para inhibir y controlar el crecimiento de microbios. La composicion comprende por lo menos un peptido quimicamente modificado con actividad antimicrobiana y por lo menos un vehiculo. El metodo comprende la administracion de una cantidad efectiva para la prevencion, inhibicion y terminacion del crecimiento microbiano para usos industriales, farmaceuticos, en el hogar y para el cuidado personal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21244100P | 2000-06-16 | 2000-06-16 | |
PCT/US2001/019400 WO2001098362A2 (en) | 2000-06-16 | 2001-06-15 | Chemically-modified antimicrobial peptides, compositions and methods of production and use |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012326A true MXPA02012326A (es) | 2005-04-19 |
Family
ID=22791026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012326A MXPA02012326A (es) | 2000-06-16 | 2001-06-15 | Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6858581B2 (es) |
EP (1) | EP1294740A2 (es) |
JP (1) | JP2004501166A (es) |
AU (1) | AU2001268512A1 (es) |
BR (1) | BR0111718A (es) |
CA (1) | CA2412011A1 (es) |
IL (1) | IL153360A0 (es) |
MX (1) | MXPA02012326A (es) |
PL (1) | PL363153A1 (es) |
WO (1) | WO2001098362A2 (es) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6061201A (en) * | 2000-05-26 | 2001-12-03 | Kanji Takada | Nonoral preparation having three-layer structure |
US20030194445A1 (en) * | 2001-11-12 | 2003-10-16 | Kuhner Carla H. | Compositions and methods of use of peptides in combination with biocides and/or germicides |
KR20040094677A (ko) * | 2002-01-29 | 2004-11-10 | 와이어쓰 | 코넥신 헤미채널 조절을 위한 조성물 및 방법 |
AU2003268467A1 (en) * | 2002-09-04 | 2004-03-29 | Biolab, Inc. | Disinfection of reverse osmosis membrane |
US20050058689A1 (en) * | 2003-07-03 | 2005-03-17 | Reactive Surfaces, Ltd. | Antifungal paints and coatings |
US20100210745A1 (en) * | 2002-09-09 | 2010-08-19 | Reactive Surfaces, Ltd. | Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes |
US20100233146A1 (en) * | 2002-09-09 | 2010-09-16 | Reactive Surfaces, Ltd. | Coatings and Surface Treatments Having Active Enzymes and Peptides |
US20090238811A1 (en) * | 2002-09-09 | 2009-09-24 | Mcdaniel C Steven | Enzymatic Antimicrobial and Antifouling Coatings and Polymeric Materials |
US8172395B2 (en) * | 2002-12-03 | 2012-05-08 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
WO2004052403A1 (ja) * | 2002-12-11 | 2004-06-24 | Santen Pharmaceutical Co., Ltd. | 眼科用保存剤 |
US8618066B1 (en) * | 2003-07-03 | 2013-12-31 | Reactive Surfaces, Ltd., Llp | Coating compositions having peptidic antimicrobial additives and antimicrobial additives of other configurations |
MXPA06001288A (es) * | 2003-07-31 | 2006-04-11 | Upjohn Co | Formulacion dispersable de un agente anti-inflamatorio. |
CA2538680A1 (en) | 2003-09-26 | 2005-04-07 | Bristol-Myers Squibb Company | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
FR2870243B1 (fr) * | 2004-05-11 | 2010-11-19 | Centre Nat Rech Scient | Conjugues tripeptidiques agonistes de la msh |
FR2870244B1 (fr) | 2004-05-11 | 2011-01-07 | Centre Nat Rech Scient | Conjugues dipeptidiques antagonistes de l'alpha-msh |
FR2870242B1 (fr) * | 2004-05-11 | 2010-08-20 | Inst Europeen Biologie Cellulaire | Peptides ou conjugues peptidiques derives de la msh et leur utilisation dans le traitement cosmetique de la canitie. |
US20060147504A1 (en) * | 2004-12-30 | 2006-07-06 | Bobby Corry | Feminine anti-itch cloth |
US8252308B2 (en) * | 2005-01-27 | 2012-08-28 | C.B. Fleet Company Inc. | Feminine anti-itch gel |
US20090030179A1 (en) * | 2005-02-15 | 2009-01-29 | Toagosei Co., Ltd | Antimicrobial peptide and use thereof |
FR2883164A1 (fr) * | 2005-03-15 | 2006-09-22 | Oreal | Composition cosmetique anhydre contenant un agent favorisant la microcirculation et un polyol, ses utilisations |
WO2006097350A1 (en) * | 2005-03-15 | 2006-09-21 | L'oreal | Anhydrous cosmetic composition containing an agent for promoting the microcirculation and a polyol, uses thereof |
US20070020220A1 (en) * | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
AU2014271339B2 (en) * | 2005-04-27 | 2016-11-03 | The Procter & Gamble Company | Personal care compositions |
US9616011B2 (en) | 2005-04-27 | 2017-04-11 | The Procter & Gamble Company | Personal care compositions |
JP2009542587A (ja) * | 2006-07-07 | 2009-12-03 | ▲張輝▼ | 医療美容分野におけるポリエン酸カルシウムの利用方法 |
ES2350806T3 (es) * | 2006-12-28 | 2011-01-27 | Kaken Pharmaceutical Co., Ltd. | Composición de gel para el tratamiento de micosis. |
BRPI0807207A2 (pt) * | 2007-02-02 | 2014-06-17 | Greenpharma Sas | Composto que inibe metalo-ectopeptidase, composição contendo composto, uso do composto e processo de tratamento cosmético da pele humana ou na membrana mucosa |
EP2494993B1 (en) | 2007-05-04 | 2018-08-01 | Marina Biotech, Inc. | Amino acid lipids and uses thereof |
KR101561709B1 (ko) * | 2007-06-27 | 2015-10-22 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 올리고펩티드 티로시나제 억제제 및 그의 용도 |
CN101795703B (zh) * | 2007-06-27 | 2015-05-06 | 里兰斯坦福初级大学理事会 | 肽酪氨酸酶抑制剂及其应用 |
US20100239682A1 (en) * | 2007-09-17 | 2010-09-23 | Antoine Andremont | Colonic delivery of antimicrobial agents |
EP2197495A2 (en) * | 2007-10-02 | 2010-06-23 | MDRNA, Inc. | Lipopeptides for delivery of nucleic acids |
US8143206B2 (en) * | 2008-02-21 | 2012-03-27 | S.C. Johnson & Son, Inc. | Cleaning composition having high self-adhesion and providing residual benefits |
US9410111B2 (en) | 2008-02-21 | 2016-08-09 | S.C. Johnson & Son, Inc. | Cleaning composition that provides residual benefits |
US9481854B2 (en) | 2008-02-21 | 2016-11-01 | S. C. Johnson & Son, Inc. | Cleaning composition that provides residual benefits |
BRPI0908179A2 (pt) * | 2008-02-21 | 2015-11-24 | Johnson & Son Inc S C | composição de limpeza possuindo alta auto-adesão e provendo benefícios residuais |
US8993502B2 (en) | 2008-02-21 | 2015-03-31 | S. C. Johnson & Son, Inc. | Cleaning composition having high self-adhesion to a vertical hard surface and providing residual benefits |
US8980813B2 (en) | 2008-02-21 | 2015-03-17 | S. C. Johnson & Son, Inc. | Cleaning composition having high self-adhesion on a vertical hard surface and providing residual benefits |
WO2010019652A1 (en) * | 2008-08-13 | 2010-02-18 | Dow Global Technologies Inc. | Process of fabricating peptide-coated fibers |
US20100040879A1 (en) * | 2008-08-13 | 2010-02-18 | Koopmans Rudolf J | Peptide-coated fibers |
GB0818072D0 (en) | 2008-10-02 | 2008-11-05 | Lytix Biopharma As | Compounds |
GB0818074D0 (en) * | 2008-10-02 | 2008-11-05 | Lytix Biopharma As | Treatment of biofilms |
UA106606C2 (uk) * | 2009-03-16 | 2014-09-25 | Родія Оперейшнс | Стабілізована біоцидна композиція |
IN2012DN00390A (es) | 2009-06-18 | 2015-08-21 | Neobiotics Ab | |
WO2011034931A2 (en) * | 2009-09-15 | 2011-03-24 | Reactive Surface, Ltd. | Anti-fouling paints and coatings |
US8937039B2 (en) * | 2009-10-05 | 2015-01-20 | The Medical College Of Wisconsin, Inc. | Peptide-based peroxidase inhibitors and methods of using same |
US8673847B2 (en) * | 2009-10-05 | 2014-03-18 | The Medical College Of Wisconsin, Inc. | Peptide based peroxidase inhibitors and methods of using same |
EP2509614A4 (en) * | 2009-12-07 | 2014-08-06 | Univ Ben Gurion | ANTIMICROBIAL WATER TREATMENT MEMBRANES AND MANUFACTURE THEREOF |
CN102958520A (zh) * | 2010-05-20 | 2013-03-06 | 郑忠铉 | 具抗细菌及抗真菌效果的皮肤外用组合物 |
WO2012153337A2 (en) * | 2011-05-11 | 2012-11-15 | Technion Research & Development Foundation Ltd. | Anti-microbial peptides and uses of same |
CN102657583B (zh) * | 2012-06-02 | 2013-07-10 | 哈尔滨工业大学 | 一种含蟾肽抗生素唇膏及其制备方法 |
EP2873675A1 (en) * | 2013-11-15 | 2015-05-20 | The Medical College of Wisconsin, Inc. | Peptide-based peroxidase inhibitors and methods of using same |
DE112014003589B4 (de) | 2013-12-03 | 2023-10-19 | Istanbul Teknik Universitesi | Eine antibakterielle Membran und ein Herstellungsverfahren dafür |
BR112017009601B8 (pt) * | 2014-11-11 | 2022-08-09 | Johnson & Johnson Consumer Inc | Derivados de aminoácidos e composição que os compreende |
EP3527192B9 (en) * | 2014-11-11 | 2022-04-27 | Johnson & Johnson Consumer Inc. | Amino acid derivatives and their uses |
BR112018076309A8 (pt) | 2016-06-17 | 2022-06-28 | Univ Erasmus Med Ct Rotterdam | Compostos de geminóide e seus usos |
RU2678987C2 (ru) * | 2017-04-28 | 2019-02-05 | Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" | Пептид для лечения болезни альцгеймера |
JP2019119725A (ja) * | 2018-01-11 | 2019-07-22 | スリーエム イノベイティブ プロパティズ カンパニー | 撥菌性組成物、撥菌性コーティング及びその形成方法、並びに撥菌性コーティングを有する物品 |
CN109745235A (zh) * | 2019-03-20 | 2019-05-14 | 北京周整无为健康管理有限责任公司 | 一种基于拉长石的牙膏及其用途 |
CN109748949B (zh) * | 2019-03-21 | 2022-06-03 | 川北医学院附属医院 | 一种抗菌肽及其应用 |
GB202008980D0 (en) * | 2020-06-12 | 2020-07-29 | Amicoat As | Medical devices and materials |
GB202008978D0 (en) * | 2020-06-12 | 2020-07-29 | Amicoat As | Antimicrobial formulation |
JP2024042716A (ja) * | 2021-02-05 | 2024-03-29 | 日産化学株式会社 | 布類又は紙類汚染防止材料 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1184770C2 (de) * | 1961-06-01 | 1965-09-02 | Hoffmann La Roche | Verfahren zur Herstellung von antibacteriell wirksamen Peptiden |
GB1237918A (es) * | 1967-08-08 | 1971-07-07 | ||
US4448715A (en) * | 1981-11-02 | 1984-05-15 | University Of Miami | Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein |
EP0175649B1 (de) | 1984-09-19 | 1991-01-02 | Ciba-Geigy Ag | Substituierte Carbodiimide |
FR2611205B1 (fr) * | 1987-02-20 | 1990-03-02 | Serbio | Dipeptides, procede de preparation et utilisation dans le dosage de proteases |
ES2020148A6 (es) | 1990-06-07 | 1991-07-16 | Consejo Superior Investigacion | Procedimiento para la sintesis de dipeptidos de n-alfa-acil arginina de cadena grasa y amino-acidos puros como tensioactivos ionicos de accion antimicrobiana. |
US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
ATE176239T1 (de) * | 1990-11-21 | 1999-02-15 | Iterex Pharma Lp | Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen |
US5631228A (en) * | 1991-11-01 | 1997-05-20 | Periodontix, Inc. | Anti-fungal and anti-bacterial histatin-based peptides |
US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
DE4310632A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Lineare Adhäsionsinhibitoren |
US5440016A (en) * | 1993-06-18 | 1995-08-08 | Torrey Pines Institute For Molecular Studies | Peptides of the formula (KFmoc) ZZZ and their uses |
WO1995019370A1 (en) * | 1994-01-18 | 1995-07-20 | Magainin Pharmaceuticals Inc. | Ion-channel forming amphiphilic peptides having n-terminal modifications |
US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
JP3810821B2 (ja) | 1994-12-26 | 2006-08-16 | 森永乳業株式会社 | ペプチド誘導体と、その用途 |
US5679364A (en) * | 1995-06-07 | 1997-10-21 | Lee County Mosquito Control District | Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments |
US6180604B1 (en) | 1996-08-21 | 2001-01-30 | Micrologix Biotech Inc. | Compositions and methods for treating infections using analogues of indolicidin |
US6126939A (en) * | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
EP1028977B1 (de) * | 1997-09-16 | 2003-11-26 | FORSSMANN, Wolf-Georg | Bifidogene peptide und deren verwendung |
AU1684099A (en) * | 1997-12-26 | 1999-07-19 | Kureha Chemical Industry Co., Ltd. | Amino acid derivatives |
AU2337599A (en) * | 1998-01-23 | 1999-08-09 | Microcide Pharmaceuticals, Inc. | Efflux pump inhibitors |
EP1089755B1 (en) * | 1998-06-26 | 2004-02-18 | N.V. Nutricia | Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
WO2000002142A2 (de) | 1998-06-30 | 2000-01-13 | Siemens Aktiengesellschaft | Verfahren und anordnung zur ermittlung eines informationsgehalts mindestens zweier elektronischer objekte bezüglich eines vorgegebenen elektronischen referenzobjekts |
ES2295016T3 (es) * | 1999-03-24 | 2008-04-16 | Zengen, Inc. | Secuencias antimicrobianas de aminoacidos derivadas de la hormona estimulante de los alfa-melanocitos. |
-
2001
- 2001-06-15 AU AU2001268512A patent/AU2001268512A1/en not_active Abandoned
- 2001-06-15 JP JP2002504317A patent/JP2004501166A/ja active Pending
- 2001-06-15 CA CA002412011A patent/CA2412011A1/en not_active Abandoned
- 2001-06-15 BR BR0111718-1A patent/BR0111718A/pt not_active Application Discontinuation
- 2001-06-15 US US09/882,781 patent/US6858581B2/en not_active Expired - Fee Related
- 2001-06-15 MX MXPA02012326A patent/MXPA02012326A/es unknown
- 2001-06-15 EP EP01946464A patent/EP1294740A2/en not_active Withdrawn
- 2001-06-15 WO PCT/US2001/019400 patent/WO2001098362A2/en not_active Application Discontinuation
- 2001-06-15 IL IL15336001A patent/IL153360A0/xx unknown
- 2001-06-15 PL PL01363153A patent/PL363153A1/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6858581B2 (en) | 2005-02-22 |
EP1294740A2 (en) | 2003-03-26 |
AU2001268512A1 (en) | 2002-01-02 |
WO2001098362A3 (en) | 2002-12-05 |
JP2004501166A (ja) | 2004-01-15 |
US20030050247A1 (en) | 2003-03-13 |
WO2001098362A2 (en) | 2001-12-27 |
BR0111718A (pt) | 2003-09-09 |
PL363153A1 (en) | 2004-11-15 |
IL153360A0 (en) | 2003-07-06 |
CA2412011A1 (en) | 2001-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02012326A (es) | Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso. | |
WO2003091276A3 (en) | Compositions and methods of use of peptides in combination with biocides and/or germicides | |
WO2005019241A3 (en) | Cationic antimicrobial peptides and compositions thereof | |
PL316033A1 (en) | Acidified nitrite as an agent against micro-organisms | |
WO2001098364A3 (en) | Peptides, compositions and methods for the treatment of burkholderia cepacia | |
WO2000034265A3 (en) | Quinoline-indole antimicrobial agents | |
EP1483366A4 (en) | ANTIMICROBIAL COMPOSITION | |
ES2177422A1 (es) | Composiciones acaricidas. | |
MXPA04000192A (es) | Composicion que tiene actividad bacteriostatica y bactericida contra esporas bacterianas y celulas vegetativas y proceso para tratar alimentos con la misma. | |
EP1015011A4 (en) | PEPTIDE NUCLEIC ACIDS WITH ANTIBACTERIAL ACTIVITY | |
NZ523183A (en) | Isolated cationic, polyphemusin-like peptideS having two anti-parallel beta strands stabilized by two disulfide bonds, a beta hairpin loop and antimicrobial activity useful to inhibit microbial growth | |
TWI256292B (en) | Reduction inhibitory agent for active oxygen eliminating activity | |
WO1999067238A3 (en) | Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them | |
ATE307561T1 (de) | Verwendung von spezifischen fettstoffen zur modifizierung der physico-chemischen eigenschaften der haut und/oder der schleimhaut als mittel zur verhinderung oder reduzierung der adhäsion von mikro-organismen darauf | |
HK1053613A1 (en) | Derivatives of laspartomycin and preparation and use thereof | |
WO2003009859A1 (fr) | Immunotherapie pour humains | |
WO2001012668A9 (en) | Cathelicidin-derived peptides with broad spectrum antimicrobial activity | |
ATE260097T1 (de) | Hopfensäuren zur hemmung von staphylococcus aureus | |
NZ517872A (en) | Multidrug efflux pumps | |
WO2002102835A8 (en) | Novel antimicrobial compounds | |
WO1998014567A3 (en) | Methods and compositions for inhibiting bacterial growth | |
AU2003226092A1 (en) | Method for inhibiting differentiation and formation of coniferophyta male flower by treatment with prohexadione compounds | |
WO2003037331A8 (en) | Use of tetramisole and its derivatives against spore producing microorganisms | |
CA2439928A1 (en) | Bacterial translocation inhibitor and method of inhibiting bacterial translocation | |
MX9603535A (es) | Nitrito acido como un agente antimicrobiano. |